AGC Biologics, a global biopharmaceutical CDMO, has appointed David Stewart as General Manager/Site Head to oversee the startup, strategic development and operational excellence in large-scale biologics production at its Boulder, CO site.
 
Mr. Stewart brings more than 20 years of leadership experience in the biotechnology and manufacturing industry, including positions with Biogen and Genentech. He will support the continuous growth of the site, while partnering with colleagues across AGC’s global network of facilities to bring new biopharmaceuticals to market.
 
“We are very happy that Mr. Stewart is joining us as General Manager/Site Head for the Boulder Site. He brings broad experience and demonstrated leadership ability from large-scale biologics drug substance operations,” said AGC Biologics Chief Technical Officer, Kasper Møller. “I am confident that Mr. Stewart will lead the Boulder Site to successful operations in support of our customers’ growing demands.”